LIOPYLIOPYOTC
Loading
Cash Flow PerformanceStrong
Percentile Rank86
3Y CAGR+7.9%
5Y CAGR+11.4%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+7.9%/yr
vs +4.5%/yr prior
5Y CAGR
+11.4%/yr
Recent deceleration
Acceleration
+3.5pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$23.67B-4.0%
2024$24.66B+385.2%
2023$5.08B-73.0%
2022$18.82B+179.6%
2021$-23.63B-271.2%
2020$13.80B-13.1%
2019$15.87B+0.5%
2018$15.79B-7.3%
2017$17.03B-26.1%
2016$23.06B-